Hepatocyte suspensions as a model for demonstration of drug hepatotoxicity.
D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D002478:Cells, Cultured; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002746:Chlorpromazine / Q000633:toxicity*; D004917:Erythromycin / Q000633:toxicity*; D066298:In Vitro Techniques; D008099:Liver / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D008954:Models, Biological; D009994:Osmolar Concentration; D051381:Rats
D004917:Erythromycin; D001219:Aspartate Aminotransferases; D002746:Chlorpromazine